Large-scale testing (Phase 3)Study completedNCT00619359
What this trial is testing
Evaluation of Fosaprepitant (MK0517) in Single Dose Schedule (0517-017)
Who this might be right for
Chemotherapy-Induced Nausea and Vomiting (CINV)
Merck Sharp & Dohme LLC 2,322